Point State Capital LP Bristol Myers Squibb CO Call Options Transaction History

Point State Capital LP

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 13, 2022	SELL	$61.48 - $73.72 $6.15 Million - $7.37 Million	-100,000 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$53.63 - $62.52 $5.36 Million - $6.25 Million	100,000 New	100,000 $6.24 Million
Q1 2021 May 14, 2021	SELL	$59.34 - $66.74 $2.97 Million - $3.34 Million	-50,000 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$57.74 - $65.43 $2.89 Million - $3.27 Million	50,000 New	50,000 $3.1 Million
Q2 2019 Aug 14, 2019	SELL	$44.62 - $49.34 $1.12 Million - $1.23 Million	-25,000 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$45.12 - $53.8 $36.3 Million - $43.3 Million	-805,000 Reduced 96.99%	25,000 $1.19 Million
Q2 2017 Aug 14, 2017	BUY	N/A	830,000	830,000 $46.2 Million

2,533

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $124B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Point State Capital LP, based on Form 13F filings with the SEC.

Stay updated on Point State Capital LP with notifications on news.